Core pillars of the practice at Pinsent Masons LLP include patent and supplementary protection certificate (SPC) strategic advice and litigation; transactions including, asset purchases & sales, corporate financing and licensing; and advice across a range of UK and EU competition issues. Charlotte Weekes heads up the life sciences team and is well-versed in contentious patent work, notably in matters involving generics and biosimilars. Joanne Ellis heads up the healthcare offering from the firm’s Birmingham office. She frequently handles private company and private equity work in the sector including investments, refinancings and disposals. Gareth Morgan is noted by peers in the market for his expertise in IP trials concerning patent entitlement and the interpretation of IP licences. Patent litigator Christopher Sharp frequently acts in cases in courts ranging from the Patents Court to the Court of Appeal, and the Supreme Court. Allistair Booth is praised for his ability to structure ‘nuanced, complex and productive deals across biotech’.
Testimonials
Collated independently by Legal 500 research team.
‘The team at Pinsent Masons have had a couple of standout years; involved in practically all the major pieces of litigation even to the extent that they appeared in trials for more than one party (with appropriate information barriers). Very impressive.’
‘Chris Sharp is a standout partner. Busy, client-focused, really good and experienced; arguably the 'partner of the year' in this area. Other key partners are Charlotte Weekes, Gareth Morgan and Tracey Roberts. Key associates are: Anna Harley, Carissa Kendall-Windless. They also have a team of really helpful and user-friendly paralegals.’
Key clients
- Teva Pharmaceutical Industries Ltd.
- Accord Healthcare Limited
Work highlights
- Representing Teva in proceedings against BMS in multiple jurisdictions, including the UK, in relation to the blockbuster anti-coagulant drug Eliquis (apixaban) for more than 3 years.
- Acting for Flynn Pharma on groundbreaking litigation in the UK relating to its flagship product, Circadin.